| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 06/30/2005 | CA2547804A1 Novel thiazole derivatives |
| 06/30/2005 | CA2547600A1 Novel herbicides |
| 06/30/2005 | CA2547518A1 Quinolines useful in treating cardiovascular disease |
| 06/30/2005 | CA2547198A1 (3,4-disubstituted)propanoic carboxylates as s1p (edg) receptor agonists |
| 06/30/2005 | CA2545294A1 Tetronic and tetramic acids as inhibitors of beta-secrease |
| 06/29/2005 | EP1548007A1 2-Pyridinylethylcarboxamide derivatives and their use as fungicides |
| 06/29/2005 | EP1548005A1 Process for producing 2-substituted pyridine derivative |
| 06/29/2005 | EP1547996A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 06/29/2005 | EP1547616A1 Preventive and/or therapeutic drugs for itch |
| 06/29/2005 | EP1546162A2 Luminescence-based methods and probes for measuring cytochrome p450 activity |
| 06/29/2005 | EP1546152A1 Epothilone derivatives |
| 06/29/2005 | EP1546146A1 POLYMORPHIC FORMS OF ZIPRASIDONE HCl AND PROCESSES FOR THEIR PREPARATION |
| 06/29/2005 | EP1546145A1 Heterocyclic substituted piperazines for the treatment of schizophrenia |
| 06/29/2005 | EP1546143A1 Heterocyclic substituted piperazines for the treatment of schizophrenia |
| 06/29/2005 | EP1546140A2 Antimicrobial oxazolidinones, process of their preparation, and pharmaceutical compositions containing them |
| 06/29/2005 | EP1546132A1 Pyrazole derivatives as reverse transcriptase inhibitors |
| 06/29/2005 | EP1546124A1 Process for preparing substituted phenoxy-acetic acids from phenols |
| 06/29/2005 | EP1546116A1 Vanilloid receptor ligands and their use in treatments |
| 06/29/2005 | EP1546113A1 Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes |
| 06/29/2005 | EP1546109A2 Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace) |
| 06/29/2005 | EP1546099A2 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists |
| 06/29/2005 | EP1546097A1 Pyrrole derivatives as antimycobacterial compounds |
| 06/29/2005 | EP1545708A2 Heterocyclic compound for stimulating or inducing hair or eyelash growth and/or for slowing down hair loss, composition containing same, and uses thereof |
| 06/29/2005 | EP1545543A2 Novel tyrosine kinases inhibitors |
| 06/29/2005 | EP1545538A2 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 06/29/2005 | EP1545532A2 Heterocyclic compounds |
| 06/29/2005 | EP1545523A1 3-&-grave;(HETERO) ARYLMETHOXY ! PYRIDINES AND THEIR ANALOGUES ASP38 MAP KINASE INHIBITORS |
| 06/29/2005 | EP1545518A1 Broadspectrum 2-amino-benzothiazole sulfonamide hiv protease inhibitors |
| 06/29/2005 | EP1545517A1 Oxazolidin-2-one and thiazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of glaucoma |
| 06/29/2005 | EP1545513A2 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 06/29/2005 | EP1322648B1 3-(heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents |
| 06/29/2005 | EP1274701B1 [1,4']-bipiperidine compounds |
| 06/29/2005 | EP1242069B1 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies |
| 06/29/2005 | EP1184037B1 Use of 1,4-benzothiazepine derivatives as drugs overcoming carcinostatic tolerance |
| 06/29/2005 | CN1633433A N-aroyl cyclic amines |
| 06/29/2005 | CN1633429A 1-phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives |
| 06/29/2005 | CN1633420A Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors |
| 06/29/2005 | CN1633419A CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 06/29/2005 | CN1633416A Nicotinamide derivates useful as p38 inhibitors |
| 06/29/2005 | CN1633414A Chemical compounds |
| 06/29/2005 | CN1633297A Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 06/29/2005 | CN1633294A 2, 4, 5-trisubstituded thiazolyl derivatives and their antiinflammatory activity |
| 06/29/2005 | CN1631889A 3(2H)-pyridazinone derivative and its preparing process and application |
| 06/29/2005 | CN1208335C Thiazolidinedione derivative and its use as antidiabetic |
| 06/29/2005 | CN1208321C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 06/29/2005 | CN1208319C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 06/29/2005 | CN1208318C Cycloamine CCR5 receptor antagonists |
| 06/28/2005 | US6911545 Crystals of glucokinase and methods of growing them |
| 06/28/2005 | US6911464 N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses |
| 06/28/2005 | US6911463 Capable of increasing lipolysis and energy expenditure in cells and therefore is useful for treating Type 2 diabetes and/or obesity |
| 06/28/2005 | US6911462 Benzimidazole compounds for regulating IgE |
| 06/28/2005 | US6911461 For treating epilepsy, epileptogenesis, seizure disorders, convulsions, bipolar disorders, mania, depression, anxiety, migraine, neuralgia, chronic pain, neuropathic pain, cerebral ischemia, cardiac arrhythmia, myotonia, cocaine abuse |
| 06/28/2005 | US6911453 Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them |
| 06/28/2005 | US6911444 Non-steroidal IL-5 inhibitors, processes and intermediates for their preparation and pharmaceutical compositions comprising said inhibitors |
| 06/28/2005 | US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 06/28/2005 | CA2114746C Substituted triazolinones |
| 06/23/2005 | WO2005056547A2 Quinoxalines useful as inhibitors of protein kinases |
| 06/23/2005 | WO2005056541A1 α-AMINO ACID DERIVATIVES AND USE THEREOF AS MEDICINES |
| 06/23/2005 | WO2005056540A1 Heterocyclic substituted indane derivatives and related compounds for the treatment of schizophrenia |
| 06/23/2005 | WO2005056538A1 Oxazole derivatives of tetracyclines |
| 06/23/2005 | WO2005056533A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 06/23/2005 | WO2005055941A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 06/23/2005 | WO2005055940A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 06/23/2005 | WO2005055715A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives |
| 06/23/2005 | WO2005041888A3 Pyrimidin-4-one compounds, compositions and methods |
| 06/23/2005 | WO2005040156A8 Azole derivative useful as antifungal agents with reduced interaction with metabolic cytochromes |
| 06/23/2005 | WO2005039574A8 Therapeutic agent for keratoconjunctive disorder |
| 06/23/2005 | WO2005034870A3 Amide compounds and ion channel ligands and uses thereof |
| 06/23/2005 | WO2005033930A3 Process for upgrading naphtha |
| 06/23/2005 | WO2005033105A3 Vanilloid receptor ligands and their use in treatments |
| 06/23/2005 | WO2005026136A3 2, 2'-azino-bis-thiazolines and uses thereof as air- and water- stable radical precursors |
| 06/23/2005 | WO2004052366A9 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists |
| 06/23/2005 | WO2004041258A8 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 06/23/2005 | US20050137395 E.g., 6-[(7-iodoquinolin-4-yl)oxy]-N,2-dimethyl-1-benzofuran-3-carboxamide; antiproliferative agent for hyperproliferative disorders being either cancerous or noncancerous; vasculogenesis or angiogenesis inhibitors; adminstered with hypotensive agent, antitumor agents, mitotic inhibitors and others |
| 06/23/2005 | US20050137240 Administering as a neuropeptide Y antagonist a 2-[(sulfonylaminoalkyl- or carbonylaminoalkyl)cycloalkyl(alkyl)amino]-5-phenylthiazole to treat obesity and eating disorders |
| 06/23/2005 | US20050137238 Biphenyl derivatives; use in regulating and/or restoring skin lipid metabolism; for example, 1-methyl 7-{[4'-(2,4-dioxothiazolidin-5-ylmethyl)-biphenyl-3-ylmethyl]methylcarbamoyl}heptanoate, (S)-2-ethoxy-3-(3'-{[methyl-(6-oxo-6-phenyl hexanoyl) amino]methyl}biphenyl-4-yl)propionic acid |
| 06/23/2005 | US20050137232 Histone deacetylase inhibitors |
| 06/23/2005 | US20050137230 Factor Xa-inhibitors; preventing thromboembolic illnesses and tumors; 2-amino-N-(2'-methylsulfonylbiphenyl-4-yl)-3-phenylpropionamide |
| 06/23/2005 | US20050137228 Benzyl sulfonamide derivatives |
| 06/23/2005 | US20050137216 Heterocyclic sodium/proton exchange inhibitors and method |
| 06/23/2005 | US20050137215 Antiarthritic and antiinflammatory agents; analgesics; the proline derivatives do not displace gabapentin from alpha-2-delta receptors |
| 06/23/2005 | US20050137202 Heterocyclic compounds as antiinflammatory agents and cyclooxygenase inhibitors |
| 06/23/2005 | US20050137196 Medical devices employing triazine compounds and compositions thereof |
| 06/23/2005 | US20050137190 Compositions useful as inhibitors of voltage-gated sodium channels |
| 06/23/2005 | CA2549273A1 Novel m3 muscarinic acetylcholine receptor antagonists |
| 06/23/2005 | CA2549272A1 Novel m3 muscarinic acetylcholine receptor antagonists |
| 06/23/2005 | CA2548918A1 Alpha-amino acid derivatives and use thereof as medicines |
| 06/23/2005 | CA2548447A1 Heterocyclic substituted indane derivatives and related compounds for the treatment of schizophrenia |
| 06/23/2005 | CA2548172A1 Quinoxalines useful as inhibitors of protein kinases |
| 06/23/2005 | CA2547391A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 06/23/2005 | CA2546895A1 Oxazole derivatives of tetracyclines |
| 06/22/2005 | EP1544201A1 Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications |
| 06/22/2005 | EP1543017A2 Bifunctional heterocyclic compounds and methods of making and using same |
| 06/22/2005 | EP1542998A2 Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b |
| 06/22/2005 | EP1542997A2 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents |
| 06/22/2005 | EP1542996A2 Octahydro-2-h-naphtho 1,2-f indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators |
| 06/22/2005 | EP1542995A1 Novel isothiazole and isoxazole compounds as transforming growth factor (tgf) inhibitors |
| 06/22/2005 | EP1542994A1 Novel triazole and oxazole compounds as transforming growth factor (tgf) inhibitor |
| 06/22/2005 | EP1542990A1 Novel imidazole compounds as transforming growth factor (tgf) inhibitors |
| 06/22/2005 | EP1542980A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |